ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,850, issued on July 14, was assigned to Alumis Inc. (South San Francisco, Calif.).

"TYK2 inhibitors and uses thereof" was invented by Bohan Jin (South San Francisco, Calif.), Qing Dong (South San Francisco, Calif.) and Gene Hung (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds of Formula (I) that are useful in treating a TYK2-mediated disorder. In some embodiments, the TYK2-mediated disorder is an autoimmune disorder, an inflammatory disorder, a proliferative disorder, an endocrine disorder, a neurological disorder, or a disorder associated with transplantation."

The patent was filed on Sept...